New mRNA cancer vaccine designed to target lymph nodes for stronger immune response New mRNA cancer vaccine designed to...
Tumors
'Most Expensive Drug' Zolgensma facing new challenge after Two Children Died 'Most Expensive Drug' Zolgensma facing new challenge after...
What is the Immunotherapy targeting ADCC for HER2+ breast cancer? What is the Immunotherapy targeting ADCC for HER2+ breast...
AstraZeneca's $1.275 billion first-in-class therapy fails first phase 3 study AstraZeneca's $1.275 billion first-in-class therapy fails first phase 3...
Heterogeneity of the tumor immune microenvironment Heterogeneity of the tumor immune microenvironment.During tumorigenesis and subsequent metastasis, malignant cells gradually...
3D real-time imaging of tumor organoids to help T-cell immunotherapy of solid tumors 3D real-time imaging of tumor organoids...
New study predicts which blood cancer patients may benefit from CAR-T cell therapy Nature Medicine: New study predicts which...
First KRAS inhibitor (Lumakras) disappointed First KRAS inhibitor (Lumakras) disappointed. Amgen's novel KRAS inhibitor Lumakras (sotorasib) is in the...
Synthetic IL-9 receptor enhances T-cell therapy to cure solid tumors without chemoradiotherapy The latest paper by the father of...
Immune checkpoint blockade (ICB) is only effective in 12.5% of patients! Immune checkpoint blockade (ICB) is only effective in...
All adults in U.S. will be received the fourth dose of COVID-19 vaccine? All adults in U.S. will be...
Seven patients die: MacroGenics closes its B7-H3-targeted solid tumor clinical trial Seven patients die: MacroGenics closes its B7-H3-targeted solid tumor...
What progress has been made in tumor radioimmunotherapy over the past decade? What progress has been made in tumor...
The mechanism by which vitamin D inhibits the spread of ovarian cancer The mechanism by which vitamin D inhibits...
The crisis of CAR-T therapy: T cells reproduce chromosomal abnormalities after Cas9 gene editing The crisis of CAR-T therapy: ...
NEJM: Oncolytic virus for fatal brain tumor in children prolongs survival by 50% NEJM: Oncolytic virus for fatal brain...
How about the Past Present and Future of non-viral CAR-T? How about the Past Present and Future of non-viral...
Molecular perspective on T cell stemness and exhaustion Molecular perspective on T cell stemness and exhaustionT cell stemness and...
Technological Changes in Tumor Immunity from Immunomics to Single-Cell Analysis and Artificial Intelligence Technological Changes in Tumor Immunity from...
New drug Zanubrutinib reduces tumor size in 80% of lymphoma patients New drug Zanubrutinib reduces tumor size in 80%...
What is the relationship between Harmful metabolites of TME and antitumor immunity? What is the relationship between Harmful metabolites...
BioNTech's CAR-T+mRNA vaccine for the treatment of solid tumors has been granted priority drug status by the European Medicines Agency...
'Viagra' helps esophageal cancer treatment: Clinical trials are coming soon 'Viagra' helps esophageal cancer treatment: Clinical trials are coming...
What hurdles are there for in vivo CAR-T cell therapy to go to the clinic? What hurdles are there...
The pesticide residues found in Häagen-Dazs vanilla ice cream in Taiwan The pesticide residues found in Haagen-Dazs vanilla ice...
First in the world: Innovative treatment for uterine fibroids approved by EU First in the world: Innovative treatment for...
CAR-T patent: BMS appeals to US Supreme Court for $1.2 billion in damages from Gilead The CAR-T patent: BMS...
The synthesis of IL-9 receptors enhances T cell therapy to cure solid tumors The latest Nature paper by the...
PD-1 immune combination therapy advances to first-line treatment of gastric cancer PD-1 immune combination therapy advances to first-line treatment of...
UK MHRA accepts marketing application for almetinib UK MHRA accepts marketing application for almetinib. On June 14, EQRx, Inc...
